gila monster venom glp 1 monster: meet the lizard whose venomous bite is saving lives Weight Loss and Gila monsters.

Pfizer terminated lotiglipron in October 2023 due to dose-dependent liver enzyme elevations, and subsequently discontinued danuglipron in April 2025 after a single case of potential drug-induced liver injury was identified in a dose-optimization study

How to diagnose sarcopenic obesity in candidates for bariatric surgery

Strength training: Regular strength training (such as using weights or resistance bands) two to three times per week helps minimize muscle loss and ensures that most weight lost is fat

A recent systematic review and meta-analysis encompassing 76 RCTs demonstrated that GLP-1 RA therapy considerably elevated the probability of gallbladder and biliary disorders (pooled relative risk, 1.37

This is a significant step forward for metabolic health

The Gala GLP-1 health assessment requests disclosure of personal or family history of breast cancer, endometrial cancer, blood clots, stroke, heart attack, or active liver disease for provider review